One of the primary manifestations is muscle weakness and functional decline
Deng F, Wu W, Fan X, Zhong X, Wang N, Wang Y, Pan T, Du Y (2023Aug) Dulaglutide protects mice against diabetic sarcopenia-mediated muscle injury by inhibiting inflammation and regulating the differentiation of myoblasts
#RegulatoryAffairs #FDA #PharmaRegulatory #OTC #DrugApproval To view or add a comment, sign in The FDAs Pharmacy Compounding Advisory Committee has just voted (July 2324, 2026) in favor of adding 6 of 7 peptides to the 503A bulk substances list
Compared to GIP, which has normal secretion but poor response in patients with T2D, GLP-1, which has low secretion but preserved response, is an important target in the development of antidiabetic drugs
Ozempic and libido Another study reviewed social media content , and found that some people reported increased sex drive with GLP-1 medications, such as Ozempic